Related Experiment Video

Updated: Jun 29, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.5K

Role of CCRL2 in the Pathogenesis of Experimental Autoimmune Myocarditis via P21-Activated Kinase 1/NOD-Like Receptor

Lin Chen1,2, Jing Meng2, Jia Zheng3

  • 1The First Central Clinical School, Tianjin Medical University.

International Heart Journal
|March 31, 2024
PubMed

Insights

Chemokine (C C motif) receptor-like 2 (CCRL2) plays a key role in experimental autoimmune myocarditis (EAM). Downregulating CCRL2 improved cardiac function and reduced inflammation, suggesting CCRL2 as a potential therapeutic target for myocarditis.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Molecular Medicine

Background:

  • Myocarditis is a serious global health issue.
  • Understanding the molecular mechanisms of myocarditis is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of Chemokine (C C motif) receptor-like 2 (CCRL2) in experimental autoimmune myocarditis (EAM).
  • To explore the regulatory mechanisms of CCRL2 in EAM pathogenesis.

Main Methods:

  • EAM was induced in a mouse model using α-myosin-heavy chain.
  • Cardiac function, inflammation markers, apoptosis, and gene expression were analyzed.
  • Transcriptome sequencing identified differentially expressed genes and potential therapeutic targets.

Main Results:

  • EAM induction led to increased cardiac damage, inflammation, and apoptosis.
  • Transcriptome analysis identified CCRL2 as a key differentially expressed gene.
  • CCRL2 knockdown significantly improved cardiac function and reduced inflammation by inhibiting the PAK1/NLRP3 pathway.

Conclusions:

  • CCRL2 is implicated in the development of EAM.
  • Targeting CCRL2 may offer a novel therapeutic strategy for myocarditis.
  • CCRL2 regulates EAM through the p21-activated kinase 1/NOD-like receptor protein 3 (PAK/NLRP3) signaling pathway.
Keywords:
Bioinformatics analysisDifferentially expressed genesInflammationPyroptosisTranscriptome sequencing

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

427
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

9.9K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K